Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/05/1996 | CA2220955A1 A novel human purinergic p2u receptor |
12/05/1996 | CA2220648A1 Coanda effect gene delivery instrument and method of use |
12/05/1996 | CA2220530A1 Improved method for obtaining full-length cdna sequences |
12/05/1996 | CA2219861A1 .delta.p62, variants thereof, nucleic acid sequences and uses thereof |
12/04/1996 | EP0745852A1 Use of functional derivatives of the intercellular adhesion molecule ICAM-1 in anti-viral therapy |
12/04/1996 | EP0745849A2 Sample processing method for whole blood |
12/04/1996 | EP0745690A2 Detectably labeled dual conformation oligonucleotide Probes, Assays and Kits |
12/04/1996 | EP0745686A1 The use of DNA polymerase 3'-intrinsic editing activity |
12/04/1996 | EP0745678A2 Novel microorganism, its use and process for the preparation of L-alpha-aminoacids |
12/04/1996 | EP0745676A1 Thermostable DNA polymerases |
12/04/1996 | EP0745675A2 A method of amplifying nucleic acid and a reagent therefor |
12/04/1996 | EP0745674A2 Helicobacter polypeptides, their production and use |
12/04/1996 | EP0745673A2 Catalytic antibody regulated prodrug therapy |
12/04/1996 | EP0745672A2 Production of recombinant factor VIII in the presence of liposome-like substances of mixed composition |
12/04/1996 | EP0745671A2 Recombinant DNA sequences encoding feedback inhibition released enzymes, plasmids comprising the recombinant DNA sequences, transformed microorganisms useful in the production of aromatic amino acids, and a process for preparing aromatic amino acids by fermentation |
12/04/1996 | EP0745668A2 DNA coding for sulfotransferase |
12/04/1996 | EP0745140A1 Circularizing nucleic acid probe able to interlock with a target sequence through catenation |
12/04/1996 | EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy |
12/04/1996 | EP0745135A1 Method for exponential amplification of nucleic acid by a single unpaired primer |
12/04/1996 | EP0745134A1 Nucleic acid delivery system, method of synthesis and uses thereof |
12/04/1996 | EP0745133A1 Recombinant infectious bovine rhinotracheitis virus s-ibr-052 and uses thereof |
12/04/1996 | EP0745131A1 Targeting gene therapy |
12/04/1996 | EP0745130A1 Heterologous g protein coupled receptors expressed in yeast, their fusion with g proteins and use thereof in bioassay |
12/04/1996 | EP0745129A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use |
12/04/1996 | EP0745128A1 Hepatitis b virus mutants, reagents and methods for detection |
12/04/1996 | EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development |
12/04/1996 | EP0745126A1 High lysine derivatives of alpha-hordothionin |
12/04/1996 | EP0745125A1 Hematopoietic protein and materials and methods for making it |
12/04/1996 | EP0745124A1 Mammalian cell cycle protein |
12/04/1996 | EP0745123A1 pp32: A NEWLY IDENTIFIED CD45-ASSOCIATED PROTEIN |
12/04/1996 | EP0745122A1 Galanin receptor, nucleic acids, transformed cells and uses thereof |
12/04/1996 | EP0745121A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
12/04/1996 | EP0745094A1 Superagonists and antagonists of h il-6, and 3d modelling method for their selection |
12/04/1996 | EP0745092A1 Peptide inhibitors of urokinase receptor activity |
12/04/1996 | EP0745091A1 Use of angiotensin ii analogs in tissue repair |
12/04/1996 | EP0744958A1 Polyclonal antibody libraries |
12/04/1996 | EP0744956A1 Peptides and methods against diabetes |
12/04/1996 | EP0744953A1 Erythropoietin analog compositions and methods |
12/04/1996 | EP0744901A1 Isolation of lactoferrin from milk |
12/04/1996 | EP0744894A1 Self-assembling multimeric nucleic acid constructs |
12/04/1996 | EP0744891A1 Transgenic fibrinogen |
12/04/1996 | EP0744888A1 Corn plants and products with improved oil composition |
12/04/1996 | EP0479920B1 Novel antibodies reactive with human carcinomas |
12/04/1996 | CN1137294A Use of alpha-1,4-glucan lyase for preparation of 1,5-D-anhydrofructose |
12/04/1996 | CN1137293A Gene encoding carboxypeptidase of aspergillus niger |
12/04/1996 | CN1137289A Protease-containing cleaning compositions |
12/04/1996 | CN1137288A Bleaching compositions comprising protease enzymes |
12/03/1996 | US5581476 Computer-based methods and articles of manufacture for preparing G-CSF analogs |
12/03/1996 | US5580990 Medical diagnosis |
12/03/1996 | US5580969 Antisense oligonucleotides directed against human ICAM-I RNA |
12/03/1996 | US5580968 Useful in diagnosing and following the course of rheumatoid arthitis |
12/03/1996 | US5580967 Optimized catalytic DNA-cleaving ribozymes |
12/03/1996 | US5580958 Dna binding protein |
12/03/1996 | US5580859 Biological injections into mamalian muscle of dna to express a therapeutic protein, polypeptide or peptide; vaccines; administering a dystrophin gene correcting muscular dystrophy |
12/03/1996 | US5580852 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi |
12/03/1996 | US5580788 Use of immunoglogulin-binding artificial proteins as molecular weight markers |
12/03/1996 | US5580787 Nontoxic food starter culture |
12/03/1996 | US5580782 Acetic acid bacterium, plasmid derived from said bacterium and shuttle vectors constructed with said plasmid |
12/03/1996 | US5580777 Generation of neural precursor cell lines |
12/03/1996 | US5580776 Having genetic material stably incorporated |
12/03/1996 | US5580775 Excitatory amino acid neurotransmission in cns synapses |
12/03/1996 | US5580774 Anticarcinogenic agents |
12/03/1996 | US5580771 Phosphodiesterases catalyze hydrolysis of cyclic nucleotides, and control cellular concentration of cyclic nucleotides |
12/03/1996 | US5580768 Method for the production of proteins in plant fluids |
12/03/1996 | US5580767 Some of internucleotide linkages within oligonucleotide are phosphorothioate linkages |
12/03/1996 | US5580766 A mutated oncoretroviral gag capsid protein containing a nuclear localization signal and an exogenous gene to allow the exogenous gene to enter in the nucleus of a target cell to allo integration into the genome |
12/03/1996 | US5580761 Method of conferring resistance to immunodeficiency viral infection |
12/03/1996 | US5580760 FUSE binding protein and cDNA therefor |
12/03/1996 | US5580759 Polymerase chain reaction joining of dna molecules |
12/03/1996 | US5580758 For insertion into gene which expresses protein secretion in bordetello |
12/03/1996 | US5580757 Culturing mammalian cell transformed with recombinant vector including nucleotide sequence encoding cleavage site sandwiched between galactosidase and protein a coding sequences, recovering expressed fusion protein, cleaving |
12/03/1996 | US5580756 Ligand which is reactive with the cd28 receptor on t cells |
12/03/1996 | US5580755 Human pluripotent granulocyte colony-stimulating factor |
12/03/1996 | US5580754 Culturing; transformation; transfection; isolation |
12/03/1996 | US5580753 DNA encoding the human cytokine, interleukin-9 |
12/03/1996 | US5580752 Genetic engineering |
12/03/1996 | US5580739 Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2 |
12/03/1996 | US5580738 Delta-like gene expressed in neuroendocrine tumors |
12/03/1996 | US5580737 High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
12/03/1996 | US5580736 Having a cell with a reporter gene linked to a dna sequence comprising a protein binding site, a first and second fusiongene; interacting the binding proteins expressed; measuringthe expression of the reporter gene |
12/03/1996 | US5580734 Method of producing a physical map contigous DNA sequences |
12/03/1996 | US5580732 Method of DNA sequencing employing a mixed DNA-polymer chain probe |
12/03/1996 | US5580729 Generalized method for cancer assessment |
12/03/1996 | US5580727 Amli-MTg8 fusion protein resulting from T(8;21) translocation in acute myeloid leukemia |
12/03/1996 | US5580725 Method of eliminating genetic routes for bacteriophage evolution and products produced thereby |
12/03/1996 | US5580723 Comparing the activities of a segment-substituted polypeptide and the parent polypeptide; borrowing receptor binding properties from functionally divergent hormones |
12/03/1996 | US5580722 Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease |
12/03/1996 | US5580721 Assays for inhibitors of myc oncoprotein |
12/03/1996 | US5580719 Isolating genomic rna from poliovirus, employing rna sequencing to determine nucleotide at position 2493 |
12/03/1996 | US5580718 Oligonucleotides |
12/03/1996 | US5580717 Recombinant library screening methods |
12/03/1996 | US5580716 Parasite-derived resistance |
12/03/1996 | US5580703 Human adeno-associated virus integration site DNA and uses thereof |
12/03/1996 | US5580564 A pseudorabies virus having the replacement of the inducible promoter sequence of the immediate early gene to control tissue specificity; vaccines |
12/03/1996 | US5580560 Modified factor VII/VIIa |
12/03/1996 | US5580559 Hybrid plasminogen activator |
12/03/1996 | US5580558 Delivery of gene products via mesangial cells |
12/03/1996 | CA2177883A1 Polypeptides, their production and use |
12/03/1996 | CA2028140C Novel bacteriocin compositions for use as enhanced broad range |
12/03/1996 | CA1338771C Adhesion receptor for laminin and its use |